Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.5.0.2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Payables and Accruals [Abstract]    
Accrued clinical operations and trials costs $ 1,302,309 $ 365,188
Accrued product development costs 405,578 152,018
Accrued audit fees 1,500 16,500
Accrued payroll and related 109,442
Accrued other 96,222 28,573
Total $ 1,915,051 $ 562,279